Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

Status unconfirmed · Not applicable

Conditions studied: Intracranial Hemorrhages, Traumatic Brain Injury

In brief

This study is a two-stage, pivotal, prospective, non-randomized, multi-center, within patient comparison of the SENSE device and the standard diagnostic test, head CT scan in patients with a diagnosis of primary spontaneous ICH or traumatic intracranial bleeding for the detection and monitoring of intracranial hemorrhages.

Key facts

Study ID
NCT04642443
Run by
Sense Diagnostics, LLC
People needed
450
Starts
2020-12-23
Expected to finish
2024-09-30
Last updated by the study team
2023-09-28

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.